Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
Imaging and Detection of Micrometer Sized Early Stage Pancreatic Cancer by Using Endoscopic Ultra-High Resolution Optical Coherence Tomography (OCT) Using Resected Pancreatic Specimen, a Pilot Study
Ohio State University Comprehensive Cancer Center
75 participants
Mar 26, 2019
INTERVENTIONAL
Conditions
Summary
This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.
Eligibility
Inclusion Criteria3
- Immediate surgery cohort: Adult patients with pancreatic cancer or IPMN
- Immediate surgery cohort: Informed consent will be obtained
- Adult patients undergoing pancreatic resection for a presumed IPMN
Exclusion Criteria1
- Pregnant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Undergo OCT
Undergo resection will be undertaken
Labs will be obtained to test for cancer cell derived exosomes
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03711890